Article thumbnail
Location of Repository

Vaccine-induced antibody responses as parameters of the influence of endogenous and environmental factors.

By H Van Loveren, J G Van Amsterdam, R J Vandebriel, T G Kimman, H C Rümke, P S Steerenberg and J G Vos

Abstract

In laboratory animals, an adequate way to assess effects of environmental exposures on the immune system is to study effects on antigen-specific immune responses, such as after sensitization to T-cell-dependent antigens. This probably also applies to testing effects in the human population. It has thus been suggested that antibody responses to vaccination might be useful in this context. Vaccination responses may be influenced by a variety of factors other than environmental ones. One factor is the vaccine itself; a second is the vaccination procedure used. In addition, the intrinsic capacity of the recipient to respond to a vaccine, which is determined by sex, genetic factors, and age, is important. Psychological stress, nutrition, and (infectious) diseases are also likely to have an impact. We reviewed the literature on vaccine response. With regard to exogenous factors, there is good evidence that smoking, diet, psychological stress, and certain infectious diseases affect vaccination titers, although it is difficult to determine to what extent. Genetic factors render certain individuals nonresponsive to vaccination. In general, in epidemiologic studies of adverse effects of exposure to agents in the environment in which vaccination titers are used, these additional factors need to be taken into consideration. Provided that these factors are corrected for, a study that shows an association of exposure to a given agent with diminished vaccination responses may indicate suboptimal function of the immune system and clinically relevant diminished immune response. It is quite unlikely that environmental exposures that affect responses to vaccination may in fact abrogate protection to the specific pathogen for which vaccination was performed. Only in those cases where individuals have a poor response to the vaccine may exogenous factors perhaps have a clinically significant influence on resistance to the specific pathogen. An exposure-associated inhibition of a vaccination response may, however, signify a decreased host resistance to pathogens against which no vaccination had been performed

Topics: Research Article
Year: 2001
OAI identifier: oai:pubmedcentral.nih.gov:1240401
Provided by: PubMed Central

Suggested articles

Citations

  1. (1984). [Efficacy of measles vaccination in young malnourished African children] Contribution a l’etude de l’efficacite de la vaccination antirougeoleuse chez le jeune enfant Africain malnutri. Bull Soc Pathol Exot Filiales
  2. (1984). Admission criteria for immunogerontological studies in man: the SENIEUR protocol.
  3. (1998). Adverse impact of infections on antibody responses to measles vaccination.
  4. (1998). Altered cytokine production in the elderly.
  5. (1999). Altered helper T lymphocyte function associated with chronic hepatitis B virus infection and its role in response to therapeutic vaccination in humans.
  6. (1981). An immunological assessment of patients with anorexia nervosa.
  7. (1994). Analysis of the mechanism of immunodepression following heterologous antigenic stimulation during concurrent infection with Nematospiroides dubius.
  8. (1996). and the DPT-IPVHib Vaccine Study Group.
  9. (1989). Antibody induction by influenza vaccines in the elderly: a review of the literature.
  10. (1995). AntiHBV neonatal immunization with recombinant vaccine. Part II. Molecular basis of the impaired alloreactivity.
  11. (1996). Antioxidant vitamins and human immune responses. Vitam Horm
  12. (1986). Cell-mediated immunity in anorexia nervosa.
  13. (1997). Characteristics of immunologic test values in the elderly.
  14. (1996). Chronic stress alters the immune response to influenza virus vaccine in older adults.
  15. (1999). Chronic stress in elderly carers of dementia patients and antibody response to influenza vaccination.
  16. (1995). Class II HLA-DR homozygocity is associated with non-response to measles vaccine in U.S. children.
  17. (1994). Clonal dysregulation of the antibody response to tetanus-toxoid after bone marrow transplantation.
  18. (1997). Comparison of pneumococcal polysaccharide and CRM197-conjugated pneumococcal oligosaccharide vaccines in young and elderly adults.
  19. (1996). Contribution of HLA class I and class II alleles to the regulation of antibody production to hepatitis B surface antigen in humans.
  20. (1997). Contribution of human leukocyte antigens to the antibody response to hepatitis B vaccination.
  21. (1994). Cytoreductive drugs. In: Immunotoxicology and Immunopharmacology
  22. (1990). Diminished response to recombinant hepatitis B vaccine in homosexual men with HIV antibody: an indicator of poor prognosis.
  23. (1998). Distinct HLA class II alleles determine antibody response to vaccination with hepatitis B surface antigen.
  24. (1997). Effect of age, sex and smoking habits on pneumococcal antibodies in an elderly population.
  25. (1992). Effect of concurrent viral infection on systemic and local antibody responses to live attenuated and enhanced-potency inactivated poliovirus vaccines.
  26. (1990). Effect of stress and other biopsychosocial factors on primary antibody response.
  27. (1992). Effects of flavonoids on immune and inflammatory cell functions.
  28. (1967). Effects of malnutrition on smallpox and yellow fever vaccination.
  29. (1996). Essential nutrients and immunologic functions.
  30. (1994). Evaluation of immune response in infants with different nutritional status: vaccinated against tuberculosis, measles and poliomyelitis.
  31. (1997). Evaluation of nutritional status by immunologic assessment in bulimia nervosa: influence of body mass index and vomiting episodes.
  32. (1976). Evaluation of the humoral immune response of children with low level lead exposure.
  33. (1997). Factors affecting the immunogenicity and potency of tetanus toxoid: implications for the elimination of neonatal and nonneonatal tetanus as public health problems.
  34. (1988). Failure of influenza vaccination in the aged.
  35. (1978). Failure to respond to influenza vaccine in the aged: correlation with B-cell number and function.
  36. (1989). Genetic prediction of nonresponse to hepatitis B vaccine.
  37. (1998). Haplotypes comprising subtypes of the DQB1*06 allele direct the antibody response after immunisation with hepatitis B surface antigen.
  38. (1993). Helminth infection results in decreased virus-specific CD8+ cytotoxic T-cell and Th1 cytokine responses as well as delayed virus clearance.
  39. (1996). Hepatitis A vaccine response in HIV-positive persons with haemophilia.
  40. (1993). Hepatitis B vaccine responsiveness in Connecticut public safety personel.
  41. (1990). HLABw54-DR4-DRw53-DQw4 haplotype controls nonresponsiveness to hepatitis-B surface antigen via CD8-positive suppressor T cells.
  42. (1997). Host and viral factors affecting the decreased immunogenicity of Sabin type 3 vaccine after administration of trivalent oral polio vaccine to rural Mayan children.
  43. (1994). Human anti-mouse antibody suppression with cyclosporin A. Cancer 73(suppl 3):1093–1097
  44. (1993). Humoral and cellular immune response to influenza virus vaccination in aged humans. Aging
  45. (1998). Humoral immune responses to Chlamydia pneumoniae in twin discordant for smoking.
  46. (1997). Immune modulation of blood leukocytes in humans by lactic acid bacteria: criteria for strain selection.
  47. (1998). Immune response to Chlamydia pneumoniae in twins in relation to gender and smoking.
  48. (2001). Immune response to vaccine against influenza in smokers, non-smokers, and,
  49. (1980). Immune responses to measles and smallpox vaccinations in malnourished children.
  50. (1981). Immunity to diphtheria, pertussis tetanus and poliomyelitis in children with acute lymphocytic leukemia after cessation of chemotherapy.
  51. (1999). Immunity to poliomyelitis, diphtheria and tetanus in pediatric patients before and after renal or liver transplantation.
  52. (1988). Immunization of elderly people with high doses of influenza vaccine.
  53. (1992). Immunogenicity of combined diphtheria, tetanus, and pertussis vaccine given at 2, 3, and 4 months versus 3, 5, and 9 months of age.
  54. (1203). Immunologic effects of background exposure to polychlorinated biphenyls and dioxins in Dutch preschool children. Environ Health Perspect
  55. (1995). Immunologic effects of background prenatal and postnatal exposure to dioxins and polychlorinated biphenyls in Dutch infants.
  56. (1992). Immunosuppression induced by attenuated Salmonella: effect of LPS responsiveness on development of suppression.
  57. (1991). Immunosuppressive effects of fish oil in normal human volunteers: correlation with the in vitro effects of eicosapentanoic acid on human lymphocytes.
  58. Immunotoxicity of heavy metals. In: Immunotoxicology and Immunopharmacology
  59. (1989). Infection and cyclosporin.
  60. (1996). Influence of breast-feeding and oral poliovirus vaccine on the immunogenicity and efficacy of rotavirus vaccines.
  61. (1997). Influence of host related factors on the antibody response to trivalent oral polio vaccine in Tunisian infants.
  62. (1983). Influence of one virus infection on a second concurrent primary in vivo antiviral cytotoxic T-cell response.
  63. (1993). Influence of perceived psychological stress and distress on antibody response to low dose rDNA hepatitis B vaccine.
  64. (1999). Influence of season on antibody response to high dose rDNA hepatitis B vaccine: effects of exposure to solar UVR?
  65. (1997). Interactions between nutrition and immunity in anorexia nervosa: a 1-y follow-up study.
  66. International Programme on Chemical Safety. Principles and Methods for Assessing Direct Immunotoxicity Associated with Exposure to Chemicals. Environmental Health Criteria 180. Geneva:World Health Organization,
  67. (1993). Is there a relationship between malnutrition, inflammation, and post-vaccinal antibody response to influenza viruses in the elderly?
  68. (1978). Killed poliovirus antigen titrations in humans.
  69. (1986). Long-term immunogenicity and efficacy of hepatitis B vaccine in homosexual man.
  70. (1995). Measles and rubella antibody response after measles-mumps-rubella vaccination in children with afebrile upper respiratory tract infection.
  71. (1996). Measles antibody in vaccinated human immunodeficiency virus type 1-infected children.
  72. (1999). Measles antibody seroprevalence rates among immunized Inuit, Innu, and Caucasian subjects.
  73. (1978). Measles revaccination: persistence and degree of antibody titer by type of immune response.
  74. (1996). Measles vaccination during the respiratory virus season and risk of vaccine failure.
  75. (1997). Measles virus infection of human T cells modulates cytokine generation and IL-2 receptor alpha chain expression.
  76. (1997). Measles virus suppresses cellmediated immunity by interfering with the survival and functions of dendritic and T cells.
  77. (1996). Mechanism of suppression of cell-mediated immunity by measles virus.
  78. (1997). Microorganisms and their interaction with the immune system.
  79. (1999). Mild illness at or after measles vaccination does not reduce seroresponse in young children.
  80. (1996). Modulation of immune response to rDNA hepatitis B vaccination by psychological stress.
  81. (1997). n-3 Polyunsaturated fatty acids and cytokine production in health and disease.
  82. (1995). Osterhaus ADME. Impaired cellular immune response in harbour seals (Phoca vitulina) fed environmentally contaminated herring.
  83. (1997). Polymorphisms of the TAP2 gene may influence antibody response to live measles vaccine virus.
  84. (1992). Prevention and control of influenza A outbreaks in long-term care facilities. Infect Control Hosp Epidemiol
  85. Prospectief Vaccinatie Onderzoek. Antistofrespons bij kinderen in het Rijksvaccinatieprogramma.
  86. (1976). Protein and calorie malnutrition, cellmediated immunity, and B.C.G. vaccination in children from rural West Bengal.
  87. (1995). Protein undernutrition as the major cause of decreased immune function in the elderly: clinical and functional implications. Nutr Rev
  88. (1998). Relationship of HLA-DQA1 alleles and humoral antibody following measles vaccination.
  89. (1991). Relationship of stress, distress, and the immunologic response to a recombinant hepatitis B vaccine.
  90. (1999). Report of the Bilthoven Symposium: advancement of epidemiological studies in assessing the human health effects of immunotoxic agents in the environment and the workplace.
  91. (1998). Response to hepatitis B vaccine: multiple HLA genes are involved.
  92. (1985). Response to measles vaccine in Haitian infants 6 to 12 months old. Influence of maternal antibodies, malnutririon, and concurrent illnesses.
  93. (1981). Responses of elderly subjects to monovalent A/USSR/77 (H1N1) and trivalent A/USSR/77 (H1N1)-A/TEXAS/77 (H3N2)-B/Hong Kong/72 vaccines. Am Rev Respir Dis
  94. (1991). Revaccination with pneumococcal vaccine of elderly persons 6 years after primary vaccination.
  95. (1992). Risk assessment in immunotoxicology. I. Sensitivity and predictability of immune tests.
  96. (1993). Risk assessment in immunotoxicology. II. Relationship between immune and host resistance tests.
  97. (1993). Risk factors for lack of detectable antibody following hepatitis B vaccination of Minnesota health care workers.
  98. (1997). Routine immunizations in adult renal transplant recipients.
  99. (1994). Seroconversion rates to combined measles-mumps-rubella-varicella vaccine of children with upper respiratory tract infection. Pediatrics
  100. (1993). Specific humoral immunity in the elderly: in vivo and in vitro response to vaccination.
  101. (1992). Stress-induced modulation of the immune response to recombinant hepatitis B vaccine.
  102. (1997). Synergism of nutrition, infection, and immunity: an overview.
  103. (1998). The association between HLA class I alleles and measles vaccine-induced antibody response: evidence of a significant association.
  104. (1976). The effect of nutritional status on immune capacity and immune responses in preschool children in a rural community in India.
  105. (1985). The efficacy of DPT and oral poliomyeliotis immunization schedules initiated from birth to 12 weeks of age.
  106. (1998). The immunologic evaluation of the Yucheng children.
  107. (1998). The influence of major histocomopatibility complex class II genes and T-cell Vb repertoire on response to immunization with HBsAg.
  108. (1996). The influence of the HLA-DRB1*13 allele on measles vaccine response.
  109. (1993). Toxicological consequences of Arachlor 1254 ingestion by female rhesus (Macaca mulatta) monkeys. Part 1B. Prebreeding phase: clinical and analytical laboratory findings.
  110. (1990). Tumour necrosis factor production and cell-mediated immunity in anorexia nervosa.
  111. (1994). Vaccinating elderly people. Protecting from avoidable disease.
  112. (1996). Vaccination against tetanus in the elderly: do recommended vaccination strategies give sufficient protection [Letter].
  113. (1998). Vaccination and systemic diseases. Vaccinations and immunosuppression.
  114. (1977). Vitamin E supplementation and in vivo immune response in healthy elderly subjects. A randomized controlled trial.
  115. (1985). Vitamins and immunocompetence.

To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.